A new study of the popular injectable contraceptive Depo-Provera shows that teenagers' bone density recovers after they stop using the drug. Several previous studies have linked Depo-Provera to bone loss, raising concerns about its use among teens, a population in their peak bone-building years.
The U.S. Preventive Services Task Force issued new chlamydia-screening recommendations last week based in large part on research conducted at Group Health Center for Health Studies in collaboration with the University of Washington.
